Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Petrillo

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
Stem Cells (Dayton, Ohio)|April 5, 2020
Lin28 reprograms inner ear glia to a neuronal fateJudith S Kempfle, Ngoc-Nhi C Luu, Marco Petrillo, et al.
Anticancer Research|May 13, 2015
Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy?Giuseppe Vizzielli, Francesco Fanfani, Vito Chiantera, et al.
Journal of Minimally Invasive Gynecology|April 26, 2016
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control StudyGiuseppe Vizzielli, Alessandro Lucidi, Valerio Gallotta, et al.
Journal of Minimally Invasive Gynecology|December 3, 2014
Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomesAnna Fagotti, Barbara Costantini, Valerio Gallotta, et al.
The International Journal of Biological Markers|December 9, 2017
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancerMara Fanelli, Alessia Camperchioli, Lella Petrella, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|May 24, 2024
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women's compliance and satisfactionGiampiero Capobianco, Elisa Sanna, Alessandra Gulotta, et al.
Plos One|September 4, 2015
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical CancerMarco Petrillo, Gian Franco Zannoni, Enrica Martinelli, et al.
Journal of Gynecologic Oncology|May 11, 2019
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective studyMarco Petrillo, Massimo Zucchetti, Stefano Cianci, et al.
Gynecologic Oncology|November 3, 2007
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?Gabriella Ferrandina, Francesco Fanfani, Manuela Ludovisi, et al.
Journal of Clinical Medicine|February 10, 2024
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An UpdateNicia I Profili, Roberto Castelli, Antonio Gidaro, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Stem Cells (Dayton, Ohio)|April 5, 2020
Lin28 reprograms inner ear glia to a neuronal fateJudith S Kempfle, Ngoc-Nhi C Luu, Marco Petrillo, et al.
Anticancer Research|May 13, 2015
Does the diagnosis center influence the prognosis of ovarian cancer patients submitted to neoadjuvant chemotherapy?Giuseppe Vizzielli, Francesco Fanfani, Vito Chiantera, et al.
Journal of Minimally Invasive Gynecology|April 26, 2016
Robotic Total Mesometrial Resection versus Laparoscopic Total Mesometrial Resection in Early Cervical Cancer: A Case-Control StudyGiuseppe Vizzielli, Alessandro Lucidi, Valerio Gallotta, et al.
Journal of Minimally Invasive Gynecology|December 3, 2014
Minimally invasive secondary cytoreduction plus HIPEC versus open surgery plus HIPEC in isolated relapse from ovarian cancer: a retrospective cohort study on perioperative outcomesAnna Fagotti, Barbara Costantini, Valerio Gallotta, et al.
The International Journal of Biological Markers|December 9, 2017
Non-catalytic region of tyrosine kinase adaptor protein 2 (NCK2) pathways as factor promoting aggressiveness in ovarian cancerMara Fanelli, Alessia Camperchioli, Lella Petrella, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|May 24, 2024
Use of etonogestrel subcutaneous implant in Sardinia, Italy: women's compliance and satisfactionGiampiero Capobianco, Elisa Sanna, Alessandra Gulotta, et al.
Plos One|September 4, 2015
Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical CancerMarco Petrillo, Gian Franco Zannoni, Enrica Martinelli, et al.
Journal of Gynecologic Oncology|May 11, 2019
Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective studyMarco Petrillo, Massimo Zucchetti, Stefano Cianci, et al.
Gynecologic Oncology|November 3, 2007
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation?Gabriella Ferrandina, Francesco Fanfani, Manuela Ludovisi, et al.
Journal of Clinical Medicine|February 10, 2024
Possible Effect of Polycystic Ovary Syndrome (PCOS) on Cardiovascular Disease (CVD): An UpdateNicia I Profili, Roberto Castelli, Antonio Gidaro, et al.
Pageof 14